Keyphrases
Meta-analysis
100%
Clinical Impact
100%
Systematic Meta-analysis
100%
Carbapenem-resistant Acinetobacter Baumannii
100%
Active Screening
100%
Acinetobacter Infections
33%
Clinical Outcomes
16%
Infection Rate
16%
Negative Predictive Value
16%
High Risk
8%
Reduced Mortality
8%
Odds Ratio
8%
Confidence Interval
8%
Clinical Benefit
8%
Length of Stay
8%
Bloodstream Infection
8%
Invasive Infection
8%
Ventilator-associated Pneumonia
8%
Healthcare-associated Infections
8%
Outcome Mortality
8%
Positive Screening
8%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Acinetobacter Baumannii
100%
Carbapenem
100%
Screening Cultures
100%
Acinetobacter Infection
33%
Infection Rate
16%
Infection
8%
Odds Ratio
8%
Bloodstream Infection
8%
Ventilator-Associated Pneumonia
8%
Healthcare Associated Infection
8%
Pharmacology, Toxicology and Pharmaceutical Science
Carbapenem
100%
Acinetobacter Baumannii
100%
Acinetobacter Infection
33%
Infection Rate
16%
Infection
8%
Bloodstream Infection
8%
Healthcare Associated Infection
8%
Ventilator Associated Pneumonia
8%
Immunology and Microbiology
Acinetobacter Baumannii
100%
Infection Rate
16%